Delivery Order SPE2DR25D2206-SPE2DR26F9MF9
Award Date 1/21/26
Potential Completion Date 2/11/26
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,245.17 to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets (30-count units) with a firm fixed-price contract structure. The award was made on January 13, 2026, with an ultimate completion date of February 4, 2026, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent organization being...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets (30-count units) under a firm fixed-price contract valued at $30,993.56. This competitive award, issued on December 19, 2025, with an ultimate completion date of January 13, 2026, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $23,245.17 to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets in quantities of 30 units. This competitive award, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a $7,352.49 delivery order to AmerisourceBergen Drug Corp for 30-unit supplies of Erleada 240 mg tablets, with a completion date of November 24, 2025. This non-set-aside, firm fixed-price contract represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate operations as a major...
- The Defense Logistics Agency awarded a $7,748.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Erleada 240 mg tablets (30-unit packaging). The order is a child contract under AmerisourceBergen's parent company Cencora, Inc., and carries an ultimate completion date of February 4, 2026. This delivery order was competitively awarded with no set-aside designation, reflecting open competition among qualified pharmaceutical vendors. The place...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,117.58 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets in quantities of 120 units. This non-competitive, firm fixed-price delivery order was awarded on July 18, 2025, with an ultimate completion date of August 8, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a $7,748.39 delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $37,793.90 for 120-count supplies of Erleada 60 mg tablets, with an ultimate completion date of October 8, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under a larger indefinite delivery vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Erleada 60 mg tablets (120-count units) valued at $7,965.80, with completion scheduled for February 5, 2026. This firm fixed-price contract award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $7,558.78 delivery order to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120 count) with an ultimate completion date of May 23, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office...